This Week in Startups

Jason Calacanis covers startups, tech, markets, media, and all the hottest topics in business and technology. He also interviews the world’s greatest founders, operators, investors, and innovators.

AMA: StartX Founder Cameron Teitelman answers questions from founders! | E1056

E1056 • May 11, 2020 • 37 mins

In this episode, Jason Calacanis talks with Cameron Teitelman about his new company, Nexus Events. They discuss the state of seed investments, fostering innovation in universities, and how StartX adapts during COVID-19. They also delve into the importance of mentorship for solo founders, building a flexible culture, and managing health tech companies.

Speakers

Cameron Teitelman

Guest • 97%

Chapters

0:00	Opening
0:37	Cameron intros his AMA and describes his new company: Nexus Events
1:31	Kevin: Are seed investors investing right now? What have StartX companies been seeing lately from early-stage investors?
2:55	James: How can universities with no entrepreneurial culture mimic the success of Stanford in creating an environment that encourages building and innovation?
4:29	James: How does the accelerator structure change for current students? What are some of the common pitfalls you have seen people make starting their company whilst finishing their degree?
7:18	Presh: Could you share more about your new startup? What are you building and why?
10:15	Ashley: How are you looking at accepting companies to StartX through the COVID lense? Which companies (in your portfolio or not) do you think are particularly well-positioned for the post COVID environment?
12:43	Jean: Regarding mentorship, in what areas do solo founders need the most help with?
14:41	Annette: Will Stanford affiliated applicants get priority over referral applicants? Would consumer startup applicants that are non-COVID related be considered during this time?
17:35	Henry: What are your thoughts in terms of building a flexible but sustainable culture?
19:26	Matt: Do you take a different approach with health tech portfolio companies and educate/manage/support them separately from the rest of the portfolio?
21:21	Laura: Given that companies don't give up equity, and there is no structured program, how do you cultivate high-level engagement with your founders/companies & mentors?
25:27	Luke: Can you talk about how the collaboration between StartX and the Stanford Hospital and Clinics works? How are the grants assessed and awarded?
26:14	Jacqui: Do you see the StartX Med COVID-19 Task Force as a new model to accelerate advances in biotech or to generate solutions for other critical global issues?
27:07	Heidi: How can other med schools around the country partner with you to develop satellite programs?
29:17	Dan: Do you have any war stories about running Nexus Events during COVID and what you’ve learned from it?

Transcript

Loading transcript...

- / -